American Board of Radiology (ABR) · Verified on 2026-10-09, Asia/Hong_Kong. The workbook's generic certification-exam label is mapped to the ABR Radiation Oncology Oral Certifying Exam, the final examination in its initial-certification pathway. The assigned slug is preserved. Basis: Radiation Oncology Remote Oral Certifying Exam Guide, 2026, revised July 8, 2026, and the currently linked Radiation Oncology Study Guide: Oral Exam. The study-guide filename contains 2023 and its upload path contains 2025/07; its document text supplies no explicit revision or effective date. Eight clinical categories are specified, without percentage weights.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• Get Certified in Radiation Oncology (RO)
• Radiation Oncology Remote Oral Certifying Exam Guide, 2026
• Radiation Oncology Study Guide: Oral Exam
• Anal Cancer Treatment (PDQ), Health Professional Version
• Rectal Cancer Treatment (PDQ), Health Professional Version
• Esophageal Cancer Treatment (PDQ), Health Professional Version
• Cervical Cancer Treatment (PDQ), Health Professional Version
• Endometrial Cancer Treatment (PDQ), Health Professional Version
• Prostate Cancer Treatment (PDQ), Health Professional Version
• Testicular Cancer Treatment (PDQ), Health Professional Version
• Bladder Cancer Treatment (PDQ), Health Professional Version
• Plasma Cell Neoplasms Treatment (PDQ), Health Professional Version
• Indolent B-Cell Non-Hodgkin Lymphoma Treatment (PDQ), Health Professional Version
• Oropharyngeal Cancer Treatment (PDQ), Health Professional Version
• Nasopharyngeal Carcinoma Treatment (PDQ), Health Professional Version
• Skin Cancer Treatment (PDQ), Health Professional Version
• Breast Cancer Treatment (PDQ), Health Professional Version
• Childhood Medulloblastoma and Other CNS Embryonal Tumors Treatment (PDQ)
• Central Nervous System Tumors Treatment (PDQ), Health Professional Version
• Ewing Sarcoma Treatment (PDQ), Health Professional Version
• Non-Small Cell Lung Cancer Treatment (PDQ), Health Professional Version
• Soft Tissue Sarcoma Treatment (PDQ), Health Professional Version
• Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
• IMWG Criteria for the Diagnosis of Multiple Myeloma
• Radiotherapy-plus-cetuximab-or-cisplatin-HPV.pdf
• FDA approves pembrolizumab with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer | FDA
• Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343 - PMC
• Pancreatic Cancer Treatment (PDQ®) - NCI
• Primary Liver Cancer Treatment (PDQ®) - NCI
• Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy - PMC
• Vulvar Cancer Treatment (PDQ®) - NCI
• Hodgkin Lymphoma Treatment (PDQ®) - NCI
• Aggressive B-Cell Non-Hodgkin Lymphoma Treatment (PDQ®) - NCI